MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Ensysce Biosciences, Inc. (ENSCW)
Ensysce Biosciences, Inc. (ENSCW)
source: myfinsight.com
Decrease in cash and cash
equivalents
-$3,564,872
Prepaid expenses and
other assets
-$1,292,926
Unbilled receivable
-$420,345
Stock-based compensation
$8,743
Depreciation expense
$6,533
Accrued interest
$3,089
Net cash used in
operating activities
-$3,500,925
Net cash (used in)
provided by financing...
-$63,947
Canceled cashflow
$1,731,636
Net loss
-$3,556,415
Repayment of financed
insurance premiums
$63,947
Accounts payable
-$1,663,513
Accrued expenses and
other liabilities
-$12,633
Back